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SUMMARY	STATEMENT	
Ocular	albinism	may	be	mistaken	for	other	disorders	associated	with	congenital	
nystagmus.	We	identify	features	of	ocular	albinism,	present	in	female	carriers	that	
will	help	facilitate	an	accurate	diagnosis.	
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Abstract	
	
Introduction	
Albinism	refers	to	a	group	of	disorders	primarily	characterised	by	hypopigmentation.	
Affected	individuals	usually	manifest	both	ocular	and	cutaneous	features	of	the	
disease,		but	occasionally	hair	and	skin	pigmentation	may	appear	normal.	This	is	the	
case	in	ocular	albinism,	an	X	chromosome	linked	disorder	resulting	from	mutation	
of	GPR143.	Female	carriers	may	be	recognised	by	a	"mud-splatter"	appearance	in	
the	peripheral	retina.	The	macula	is	thought	to	be	normal	however.	
	
Methods	
Obligate	female	carriers	of	pathogenic	GPR143	alleles	were	recruited.	Molecular	
confirmation	of	disease	was	performed	only	for	atypical	cases.	Detailed	retinal	
imaging	was	performed	(colour	fundus	photography,	optical	coherence	tomography	
(OCT),	fundus	autofluorescence	(FAF)).	
	
Results	
8	individuals	were	ascertained.	A	novel	GPR143	mutation	was	identified	in	one	
family	(p.Gln328Ter).	Foveal	FAF	was	subjectively	reduced	in	6/6	patients	imaged.	A	
"tapetal-like"	pattern	of	autofluorescence	was	visible	at	the	macula	in	3/6.	
Persistence	of	the	inner	retinal	layers	at	the	fovea	was	observed	in	6/8	females.	
	
Conclusions	
Female	carriers	of	ocular	albinism	manifest	sign	of	RPE	mosaicism	at	the	macula	as	
well	as	the	peripheral	fundus.	A	tapetal-like	reflex	on	FAF	may	be	considered	the	
macular	correlate	of	"mud-splatter".	
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Introduction	
Albinism,	from	the	latin,	albus	(white),	represents	a	range	of	inherited,	congenital	
disorders	of	hypomelanosis,	typically	involving	the	skin,	hair	and	eyes.		The	
phenotype	may	be	highly	variable.	In	the	most	extreme	cases	there	is	little	or	no	
melanin	production,	whilst	milder	forms	are	associated	with	greater	levels	of	
pigmentation.
1
	Melanin	granules	are	found	in	dermal	and	follicular	melanosomes,	in	
addition	to	melanosomes	of	the	iris,	retinal	pigment	epithelium	(RPE)	and	choroidal	
stroma.
2
In	most	cases,	clinical	signs	are	present	in	all	these	tissues;	these	patients	
are	diagnosed	as	having	oculocutaneous	albinism	(OCA).
1
In	the	mildest	cases,	signs	
may	only	be	identifiable	in	the	eye,	as	this	appears	to	be	the	structure	most	sensitive	
to	pigment	dosage.	Where	the	clinical	signs	are	limited	to	the	eye,	the	term	ocular	
albinism	(OA)	is	used.
3
Very	rarely,	albinism	may	be	associated	with	additional	
syndromic	features,	leading	to	a	diagnosis	of	Chediak-Higashi	(CHS,	OMIM	214500)	
or	Hermasky-Pudlack	Syndromes(HPS,	OMIM	203300,	608233).	Other	systemic	
disorders	associated	with	hypomelanosis	(also	described	historically	as	“partial	
albinism”)	include	Griscelli	Syndrome	(GS,	OMIM	414450,	607624),	Elejalde	disease	
(ED,	OMIM	256710)	and	Tietz	syndrome	(OMIM	103500,	156845).	These	disorders	
share	dysfunction	in	exocytosis	pathways,	affecting	not	only	the	release	of	pigment	
granules	but	also	key	components	of	the	clotting	cascade	from	platelets	(HPS),	
lysosomal	trafficking	(CHS)	and	cytotoxic	granule	release	from	immune	cells	(GS).	
	
The	OA	phenotype	is	associated	with	both	autosomal	recessive	and	X-linked	
inheritance.
4,	5
It	is	likely	to	represent	the	“tip	of	the	iceberg”,	as	in	addition	to	major	
signs	that	may	only	be	apparent	in	the	eye,	subclinical	endophenotypes	are	found	in	
the	hair	and	skin;	accordingly	it	should	be	thought	of	as	a	systemic	disease.
6
	The	
most	common	form	of	OA	is	OA	type	1	(OA1,	OMIM	300500),	transmitted	as	an	X-
linked	disorder	resulting	from	mutation	ofGPR143(OA1,NM_000273).
7
GPR143	
encodes	a	G-protein	coupled	receptor	present	in	late	endosomes,	lysosomes,	and	
early	stage	melanosomes.
8
Affected	males	exhibit	the	classical	ocular	features	of	
albinism	–	reduced	visual	acuity,	nystagmus,	foveal	hypoplasia,	iris	transillumination	
defects,	reduced	fundus	pigmentation	and	chiasmal	misrouting,	but	few	if	any	extra-
	 6	
ocular	signs,	particularly	in	well-pigmented	ethnic	groups.
9
When	carefully	compared	
to	unaffected	siblings	subtle	signs	of	cutaneous	hypomelanosis	may	be	evident.
6
The	
identification	of	macromelanosomes	on	skin	biopsy	confirms	that	this	is	indeed	a	
global	disorder	of	melanisation.
10-12
	
	
Females	heterozygous	for	GPR143	mutations	are	usually	asymptomatic,	although	
signs	of	carrier	status	are	often	present,	with	a	characteristic	pattern	of	
depigmentation	evident	in	the	iris	(transillumination	defects)	and	retinal	pigment	
epithelium	(“mud	splatter	appearance”).
13,	14
Macular	changes	however	are	poorly	
described.	The	present	work	represents	a	prospective,	consecutive	case	series	
describing	the	macular	changes	present	in	mothers	of	male	probands	with	OA.	
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Methods	
Individuals	diagnosed	as	carriers	of	X-linked	OA,	and	mothers	of	boys	with	OA	were	
recruited	from	the	inherited	retinal	disease	(IRD)	clinics	at	Moorfields	Eye	Hospital,	
London,	UK.	Clinical	examinations	were	performed	by	one	of	four	retina	physicians	
experienced	in	managing	patients	with	IRD	(ATM,	MM,	ARW,	KNK).	Participants	were	
assessed	using	slit	lamp	biomicroscopy,	color	fundus	photography	(CFP),	spectral	
domain	optical	coherence	tomography	(OCT)	and	488nm	wavelength	fundus	
autofluorescence	(FAF)	(both	Spectralis,	Heidelberg	Engineering,	Heidelberg).	Visual	
acuity	was	measured	at	6	meters	with	a	Snellen	chart.	For	atypical	cases,	molecular	
genetic	confirmation	was	obtained	after	whole	exome	or	whole	genome	sequencing,	
either	as	a	participant	in	the	NIHR	BioResource	–	Rare	Diseases	project	or	an	in-
house	sequencing	study	(see	Supplementary	Methods).	Segregation	of	variants	
identified	by	whole-exome	and	whole	genome	sequencing	was	performed	by	
polymerase	chain	reaction	and	Sanger	sequencing	using	standard	protocols.
15
	
Primers	were	designed	using	ExonPrimer
16
	and	can	be	found	in	Supplementary	Table	
1.As	a	control	group,	mothers	of	children	with	OCA	were	also	recruited	to	this	study.	
They	also	underwent	detailed	retinal	imaging	but	no	genetic	investigations	were	
performed.	All	participants	provided	informed	consent,	and	research	adhered	to	the	
principles	set	out	in	the	Declaration	of	Helsinki	(2013).	
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Results	
Eight	females	were	recruited.	Four	were	ascertained	at	their	affected	son’s	hospital	
appointment.	Two	were	referred	directly,	as	their	optometrist	identified	pigmentary	
changes	at	routine	assessment.	Two	were	examined	as	part	of	a	family	survey.	In	all	
cases	there	was	at	least	one	additional	male	relative	known	to	have	OA.	No	families	
had	any	affected	female	family	members.	The	clinical	and	molecular	features	are	
described	in	Table	1	and	Figures	1-3.		
	
In	only	one	case	was	a	reduction	in	vision	recorded,	which	was	lifelong	and	non-
progressive	(Case1a).	Iris	transillumination	was	present	in	all	female	carriers;	these	
defects	were	clearly	visible	in	the	mid	to	peripheral	iris,	but	were	never	seen	
immediately	adjacent	to	the	pupillary	margin.	Nystagmus	was	never	observed.	
Retinal	examination	revealed	a	radial	pattern	of	pigmentation	in	the	peripheral	
retina	consistent	with	“mud-splatter”	(8/8).	
	
Fundus	Autofluorescence	
The	FAF	images	demonstrated	subtle	alterations	in	retinal	autofluorescence	in	all	
cases	where	imaging	was	obtained	(6/8).The	central	zone	of	hypoautofluorescence	
was	reduced	in	size,	in	keeping	with	reduced	luteal	pigment	(Figures1a	and2).	
Immediately	adjacent	to	this	an	irregular	pattern	of	autofluorescence	was	observed	
in	the	peripheral	macula,	and	in	three	cases(Cases	1b,	1c	and	6)	this	manifested	as	a	
prominent	radiating	pattern	of	hyperautofluorescence,	in	a	tapetal-like	reflex	
fashion,	not	visible	by	near	infrared	reflectance	imaging	(Figure	2)	or	color	fundus	
photography(Figure	3a).	Where	visualised,	peripheral	retinal	autofluorescence	was	
characterised	by	radial	patches	of	relative	hypoautofluorescence,	corresponding	
with	the	observed	streaks	of	relative	hyperpigmentation	in	these	regions	(Figure	2	
and	3c).For	one	mother	the	tapetal-like	reflex	appeared	to	extend	into	the	
peripheral	retina	(Case	6).	
	
Optical	Coherence	Tomography	
In	6/8	cases,	persistence	of	the	inner	retinal	layers	was	observed	(Figure	1c).Despite	
this,	a	change	in	contour	of	the	third	highly	reflective	OCT	line	(ellipsoid	zone)	was	
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always	visible	at	the	foveola,	consistent	with	physiological	lengthening	of	the	cone	
outer	segments.	The	center	of	the	fovea	was	always	avascular.	As	a	surrogate	
marker	of	macular	pigmentation,	the	visibility	of	the	sub-foveal	sclero-choroidal	
boundary	was	recorded	(Figure	1c).	This	junction	was	clearly	visible	in	5/8	mothers.	
Unusually	for	one	mother	(Case	1a)	this	boundary	was	easily	identifiable	despite	a	
choroidal	thickness	of	greater	than	500μm.In	3/8	cases	(6	eyes),the	boundary	
between	the	choroid	and	sclera	was	invisible;	here	the	choroidal	thickness	was	
estimated	to	be	greater	than	350μm.Two	mothers	had	a	normal	foveal	contour,	
without	persistence	of	the	inner	retinal	layers.		
	
Genetics	
For	two	families	where	there	was	uncertainty	regarding	the	diagnosis	molecular	
genetic	testing	was	initiated.	Retinal	examination	in	Case	4’s	sonwas	limited	by	his	
age	and	nystagmus	velocity,	and	the	results	of	electrophysiological	testingto	assess	
chiasmal	misrouting	was	equivocal.	Case	1a’s	visual	acuity	was	subnormal,	and	as	
her	full	field	electroretinogram	identified	possible	rod	system	dysfunction,	a	clinical	
diagnosis	of	OA	carrier	remained	questionable.		
	
In	both	cases,	after	bioinfomatic	filtering	and	prioritising	genes	already	implicated	in	
retinal	disease
17
	only	variants	in	GPR143	remained	as	a	possible	cause	of	disease.	
Family	1	(Cases1a-c)	harbored	a	previously	identified	pathogenic	variant,	
p.Trp292Gly,	sufficient	to	account	for	their	retinal	findings.
18
	Testing	the	son	of	Case	
4identified	a	novel	null	allele(p.Gln328Ter).	Sanger	sequencing	confirmed	each	
variant,	and	its	segregation	with	the	disease	phenotype.	In	both	cases	the	mothers	
were	heterozygous	for	the	mutation.	
	
Control	group	
In	order	to	determine	how	specific	the	above	findings	are,	five	mothers	of	children	
with	OCA	were	also	examined.	All	were	asymptomatic	and	had	normal	visual	acuity	
(6/6).	No	fundus	abnormalities	were	detected	with	CFP,	FAF	or	OCT.	Representative	
images	are	shown	in	Figure	1.	
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Discussion	
In	this	study	we	have	identified	novel	clinical	features	associated	with	carrier	status	
of	ocular	albinism–	persistence	of	the	retinal	ganglion	cell	layer	at	the	fovea,	reduced	
foveal	hypoautofluorescence,	and	irregular	peripheral	macular	autofluoresence.	In	
this	study	these	features	were	present	in	the	majority	of	cases,	and	almost	always	
associated	with	excellent	vision.	As	recognizing	rare	disorders	may	be	difficult,	these	
easy	to	detect	clinical	featuresshould	help	facilitate	a	prompt	and	accurate	diagnosis,	
both	for	carriers	of	OA	and	by	inference	their	affected	male	children.		
	
Hypomelanosisis	thought	to	occur	as	a	result	of	random	X-chromosome	inactivation.	
Unlike	the	variable	asymmetrical	scattered	mosaic	appearance	observed	in	carriers	
of	CHM(choroideremia)	and	RPGR/RP2(rod-cone	and	cone-rod	dystrophy)	
mutations,	stereotyped	pigmentary	changes	occur	in	carriers	of	X-linked	OA-	radial	
streaks	of	relative	hyperpigmentation	seen	adjacent	to	lines	of	hypopigmentation,	
commonly	referred	to	as	“mud-splatter”.
14,	19
This	reproducible	finding	however	is	
seemingly	not	in	keeping	with	a	random	event.	As	X-chromosome	inactivation	occurs	
as	an	independent	event	in	each	cell	of	the	developing	blastocyst,	a	continuous	
streak	of	hypopigmented	cells	should	not	occur	by	chance,	as	this	would	require	
aconsecutive	series	of	hundreds	of	adjacent	cells	to	each	inactivate	the	same	X-
chromosome.
19
A	more	parsimonious	explanation	is	that	all	RPE	cells	in	a	streak	of	
hypopigmentation	derive	from	a	common	RPE	progenitor,	with	the	same	X-
chromosome	inactivated.	The	pattern	seen	may	therefore	bean	observation	of	the	
migration	pattern	of	developing	RPE	cells,	preprogrammed	to	either	express	the	
mutant	or	wild-type	protein.	This	phenotype	may	be	thought	of	as	the	ocular	
equivalent	of	Blashko’s	lines,	alternating	swirls	of	hyperpigmented	and	normally	
pigmented	skin	cells	which	occur	in	a	range	of	dermatological	conditions.
20
	
	
To	date	macular	changes	have	not	been	described	in	carriers	of	OA,	as	“mud	
splatter”	is	considered	a	phenomenon	of	the	peripheral	retina.	Even	in	the	most	
extreme	cases	of	albinism	the	macula	rarely	appears	depigmented,	suggesting	that	
either	these	cells	are	relatively	spared	or	that	other	pigmented	structures	are	well	
preserved.	Melanin	granules	reside	within	the	RPE	and	choroidal	stroma.	In	their	
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absence,	the	fundus	has	a	blonde	hue,	representing	the	color	of	light	reflected	from	
the	sclera,	filtered	by	a	depigmented	RPE	and	retina.	Macula	anatomy	differs	from	
that	in	the	peripheral	retina,	with	a	greater	density	of	RPE	cells	and	a	thicker	
choroid,	both	factors	that	would	result	in	significant	residual	pigmentation.	The	
choroidal	so	contains	significant	numbers	of	erythrocytes,	adding	further	color.	
Lastly,	luteal	pigments,	lutein	and	zeaxanthin	are	stored	here	too.	A	reduction	in	
melanin	content	will	therefore	remain	relatively	disguised	at	the	macula	and	more	
apparent	in	the	periphery	where	the	retina,	RPE	and	choroid	are	thinnest.	
	
Using	multimodal	imaging	this	study	has	identified	three	novel	characteristic	traits	
identified	in	female	carriers	of	OA.	Firstly,	using	488nm	FAF	imaging,	linear	streaks,	
described	as	a	“tapetal-like”	reflex,	are	visible	at	the	macula	of	two	sisters	(Cases	1b	
and	1c)	and	a	third	unrelated	mother	(Case6).	This	finding	is	thought	to	be	unique	to	
female	carriers	of	X-linked	retinitis	pigmentosa	(XLRP),	however	no	variants	in	RPGR	
or	RP2	were	identified	after	whole	exome	sequencing	(Cases	1b	and	1c).These	
individuals	would	therefore	represent	the	first	report	of	a	tapetal-like	reflex	in	
association	with	OA,	a	finding	that	may	represent	the	macular	correlate	of	“mud-
splatter”(Figure	2).As	this	appearance	is	more	commonly	seen	in	patients	with	
primary	photoreceptor	disease	it	may	seem	curious	as	to	why	the	migratory	patterns	
of	embryonic	RPE	cells	influence	the	expression	of	a	photoreceptor	disease.	One	
explanation	may	relate	to	the	interaction	between	these	cells,	as	randomly	
distributed	dysfunctional	photoreceptors	may	only	influence	susceptible	clones	of	
RPE	cells,	themselves	distributed	in	a	non-random,	radial	manner.	
	
Secondly,	the	central	zone	of	physiological	hypoautofluorescence	appears	to	be	
reduced	in	size	in	comparison	to	healthy	controls	(Figure	1a).	Although	normal	
macular	autofluorescence	may	show	significant	inter-individual	variation,	thought	to	
relate	to	the	distribution	of	macular	pigments,	all	cases	tested	(10	eyes)	shared	the	
phenotype	of	a	single	small	zone	of	reduced	autofluorescence.	Taken	in	isolation	this	
may	have	been	a	chance	occurrence,	however	in	conjunction	with	other	structural	
changes	this	is	likely	to	be	a	further	biomarker	of	carrier	status.	
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Thirdly,	6/8female	carriers	demonstrated	subtle	persistence	of	the	retinal	ganglion	
cell	(RGC)	layer	at	the	fovea,	without	clinical	evidence	of	foveal	vascularization	or	
loss	of	acuity.	This	suggests	that	maturation	of	the	inner	retina	may	be	the	structure	
most	sensitive	to	loss	of	melanin.	In	2/8	cases	where	RGCs	were	absent	from	the	
fovea,	the	posterior	choroidal	boundary	was	also	not	visible,	perhaps	suggesting	that	
eyes	with	more	melanin	are	less	likely	to	show	signs	of	foveal	immaturity.	As	the	
fovea	may	sustain	excellent	acuity	even	when	vascularized,	one	may	now	impute	a	
hierarchy	for	sensitivity	to	melanisation.	Subtle	loss	of	pigment	results	in	foveal	RGC	
persistence,	greater	loss	of	melanin	results	in	RGC	persistence	alongside	foveal	
vascularity	(but	good	vision),	and	the	most	severe	end	of	the	spectrum	is	a	“full	
house”	of	signs	–	persistence	of	the	inner	retinal	layers/absence	of	a	foveal	pit,	
foveal	vascularization,	and	central	macular	dysfunction	(loss	of	acuity).	
Heterozygosity	for	OA	variants	may	therefore	alter	macular	melanisation	minimally,	
associated	with	clinical	findings	of	normal	acuity	and	macular	anatomy	(1/8	here),	
whilst	in	others	it	may	be	associated	with	subtle	persistence	of	foveal	RGC	(6/8	
cases).Rarely,	in	more	extreme	cases	(1/8	here),foveal	hypoplasia	and	reduced	visual	
acuity	may	be	noted.	
	
A	detailed	eye	examination	is	often	extremely	helpful	when	determining	the	
inheritance	pattern	for	genetic	disorders,	particularly	those	inherited	in	an	X-linked	
manner.	Clinical	findings	of	carrier	status	have	been	reported	both	for	eye	disease	as	
well	as	systemic	disorders	(Table	2).	Carrier	status	may	not	always	be	associated	with	
overt	clinical	signs,	as	mothers	of	boys	with	X-linked	retinoschisis	(XLRS;	OMIM	
312700)	and	congenital	stationary	night	blindness	(OMIM	310500,	300071)	have	a	
normal	retinal	appearance.	It	may	be	however	that	more	sensitive	forms	of	testing	
reveal	subtle	signs	of	dysfunction	(e.g.	Frumke	effect	detected	by	psychophysical	
testing	in	XLRS	carriers).
21
To	date	clinical	findings	in	female	carriers	of	OA	have	been	
variable,	as	most	reports	suggest	that	female	carriers	have	no	OCT	or	FAF	
abnormalities,	however	others	describe	significant	changes.
22-24
This	discrepancy	may	
in	part	relate	to	uncertainty	regarding	the	pattern	of	inheritance,	as	autosomal	
recessive	disease	may	masquerade	as	XLOA	in	the	absence	of	a	molecular	
diagnosis.
25
	The	inability	to	identifyGPR143mutations	similarly	doesn’t	exclude	this	
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as	a	cause	of	disease,	as	the	screening	technique	will	determine	the	detection	
sensitivity	which	varies	between	35-90%.
18,	26-29
It	appears	less	likely	that	novel	genes	
are	responsible	for	this	low	sensitivity,	as	linkage	analysis	in	pedigrees	with	no	
identifiable	pathogenic	variants	in	GPR143	still	maps	the	disease	to	this	locus.
18,	26,	
29
Unsurprisingly,	intronic	variants	in	GPR143have	now	been	associated	with	
disease.
30
	Other	potential	reasons	for	the	variation	in	the	clinical	findings	not	
controlled	for	in	this	study	are	chromosomal	anomalies	(Turner	syndrome	or	
variations	thereof)	and	skewed	X	chromosome	inactivation.		
	
In	summary,	multimodal	imaging	in	female	carriers	of	OA	demonstrates	
abnormalities	of	macular	as	well	as	peripheral	retinal	development.	These	patterns	
are	likely	to	occur	as	a	result	of	early	X-chromosome	inactivation,	where	clones	of	
RPE	cells	all	express	the	same	X-chromosome.	These	novel	findings	will	provide	
additional	diagnostic	clues	for	clinicians,	and	allow	vision	researchers	to	better	
understand	the	in	vivo	migration	of	human	RPE	cells.	
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Figure	Legends	
Figure	1.	Typical	retinal	changes	in	female	carriers	of	ocular	albinism	(OA)	and	
oculocutaneous	albinism	(OCA)	as	detected	by	multimodal	imaging.	(a)	488nm	
fundus	autofluorescence	demonstrating	a	smaller	than	normal	zone	of	physiological	
hypoautofluorescence	in	Case	4,	(b)	near	infrared	reflectance	appears	normal,	whilst	
(c)	optical	coherence	tomography	scans	through	the	fovea	identify	persistence	of	the	
inner	retinal	layers	in	Case	4.	Similar	changes	were	not	evident	in	five	obligate	
female	carriers	of	(recessive)	OCA	alleles.		
	
Figure	2.	Multimodal	macular	imaging	in	three	female	carriers	of	ocular	albinism.	For	
each	patient	images	of	the	right	and	left	eyes	are	shown,	with	488nm	fundus	
autofluorescence	(FAF)	(top)	and	near	infrared	reflectance	(NIR-R)	(bottom).	These	
three	individuals	have	a	radially	distributed	bright	reflex,	centered	on	the	fovea,	
apparent	on	FAF	but	not	NIR-R	imaging.	For	Case	6,	where	55°	widefield	imaging	is	
available,	this	reflex	is	seen	to	extend	into	the	peripheral	retina.	
	
	
Figure	3.	Widefield	imaging	in	female	carriers	of	ocular	albinism.	(a)	A	montage	of	
color	fundus	photographs	from	Case	1b	demonstrating	absence	of	the	tapetal-like	
reflex	seen	in	Figure	2,	and	peripheral	streaks	of	hypopigmentation.	(b)	Optos	
widefield	pseudocolor	and	(c)	green	laser	autofluorescence	imaging	in	Case	6	
similarly	identifies	peripheral	streaks	of	reduced	pigmentation	and	increased	
autofluorescence	signal.		


